Search

everythinglearnresearchcommunity

for

Search:↓

Intralesional triamcinolone acetonide is the most effective treatment for localized alopecia areata.

Contact sensitizers like DCP and SADBE are the most effective treatments for alopecia areata.

Alopecia areata is an unpredictable autoimmune hair loss condition, treated based on severity, with half of patients regrowing hair within a year without treatment.

Monthly oral corticosteroid pulses effectively treat widespread alopecia areata in young patients.

Some treatments can help with hair regrowth in alopecia areata, but results vary and long-term use is often needed without changing the disease's outcome.

Women may need different blood pressure guidelines than men for heart disease prevention.

New treatments for alopecia areata show promise, but no cure exists and responses to treatments vary.

Vitiligo is not linked to coeliac disease, but a small number of alopecia areata patients may have it, suggesting they should be tested for coeliac disease.

People with hair loss conditions experience more anxiety, depression, and a lower quality of life than those without these conditions.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Alopecia areata was most common in people in their 30s and 40s, with some family history and a higher relapse rate, and larger bald areas responded better to specific immunotherapy.

Using patients' own fat-derived cells to treat alopecia areata significantly improved hair growth and was safe.

Nail problems are common in people with alopecia areata, often leading to cosmetic and functional issues, but more research is needed for treatment guidelines.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Sulfasalazine may help treat persistent alopecia areata.

The method effectively identifies banned substances in hair loss and skin disease cosmetics.

Macrophages are essential for successful skin growth in reconstructive surgery.

Cyclosporine showed some improvement in alopecia areata but results were not statistically significant.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Methotrexate is a promising and safe treatment for severe alopecia areata, with better results when combined with corticosteroids.

Alopecia areata seriously lowers quality of life, especially affecting self-image, mental health, and social life.

Topical bexarotene 1% gel might help regrow hair in alopecia areata and is generally safe.

Certain genetic markers, especially the MICA gene, are linked to alopecia areata.

New genetic discoveries in alopecia areata could lead to better treatments.

Kids with alopecia areata may experience more stress but not necessarily feel more anxious or depressed than others.

People with alopecia areata often experience negative personal, social, and medical impacts, and need psychological support.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.